# Taurine Supplementation in Long COVID

> **NCT06721949** · PHASE2,PHASE3 · RECRUITING · sponsor: **University of Alberta** · enrollment: 300 (estimated)

## Conditions studied

- Long COVID

## Interventions

- **DRUG:** Taurine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06721949
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-18
- **Primary completion:** 2028-02
- **Final completion:** 2028-12
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-03-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06721949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06721949, "Taurine Supplementation in Long COVID". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06721949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*